Marcin Wiącek1,2, Antonina Oboz-Adaś3,4, Katarzyna Kuźniar1,2, Anna Karaś1,2, Patryk Jasielski2, Halina Bartosik-Psujek1,2. 1. Institute of Medical Sciences, University of Rzeszow, Rzeszow, Poland. 2. Department of Neurology, Clinical Regional Hospital No. 2, Rzeszow, Poland. 3. Institute of Medical Sciences, University of Rzeszow, Rzeszow, Poland. antoninaobozadas@gmail.com. 4. Department of Neurology, Clinical Regional Hospital No. 2, Rzeszow, Poland. antoninaobozadas@gmail.com.
Abstract
INTRODUCTION: Pregnancy increases the risk of acute ischemic stroke (AIS) among young women and is responsible for about 5% of maternal deaths and significant disability. Concerns of potential adverse events of imaging and reperfusion therapies in this group of patients can lead to a substantial delay or omission of treatment that can significantly worsen outcomes. OBJECTIVE: The objective of this study is to discuss main concerns of diagnosis and therapy of pregnant patients with AIS regarding neuroimaging and reperfusion treatment. RESULTS: The cumulative radiation dose of computed tomography (CT)-based entire diagnostic procedure (noncontrast CT, CT-angiography and CT-perfusion) is estimated to be below threshold for serious fetal radiation exposure adverse events. Similarly, magnetic resonance imaging(MRI)-based imaging is thought to be safe as long as gadolinium contrast media are avoided. The added risk of intravenous thrombolysis (IVT) and mechanical thrombectomy during pregnancy is thought to be very low. Nevertheless, some additional safety measures should be utilized to reduce the risk of radiation, contrast media and hypotension exposure during diagnostic procedures or reperfusion treatment. CONCLUSION: Fetal safety concerns should not preclude routine diagnostic work-up (except for gadolinium contrast media administration) in childbearing AIS women, including procedures applied in unknown onset and late onset individuals. Due to rather low added risk of serious treatment complications, pregnancy should not be a sole contraindication for neither IVT, nor endovascular treatment.
INTRODUCTION: Pregnancy increases the risk of acute ischemic stroke (AIS) among young women and is responsible for about 5% of maternal deaths and significant disability. Concerns of potential adverse events of imaging and reperfusion therapies in this group of patients can lead to a substantial delay or omission of treatment that can significantly worsen outcomes. OBJECTIVE: The objective of this study is to discuss main concerns of diagnosis and therapy of pregnant patients with AIS regarding neuroimaging and reperfusion treatment. RESULTS: The cumulative radiation dose of computed tomography (CT)-based entire diagnostic procedure (noncontrast CT, CT-angiography and CT-perfusion) is estimated to be below threshold for serious fetal radiation exposure adverse events. Similarly, magnetic resonance imaging(MRI)-based imaging is thought to be safe as long as gadolinium contrast media are avoided. The added risk of intravenous thrombolysis (IVT) and mechanical thrombectomy during pregnancy is thought to be very low. Nevertheless, some additional safety measures should be utilized to reduce the risk of radiation, contrast media and hypotension exposure during diagnostic procedures or reperfusion treatment. CONCLUSION: Fetal safety concerns should not preclude routine diagnostic work-up (except for gadolinium contrast media administration) in childbearing AIS women, including procedures applied in unknown onset and late onset individuals. Due to rather low added risk of serious treatment complications, pregnancy should not be a sole contraindication for neither IVT, nor endovascular treatment.
Authors: Noor Niyar N Ladhani; Richard H Swartz; Norine Foley; Kara Nerenberg; Eric E Smith; Gord Gubitz; Dariush Dowlatshahi; Jayson Potts; Joel G Ray; Jon Barrett; Cheryl Bushnell; Simerpreet Bal; Wee-Shian Chan; Radha Chari; Meryem El Amrani; Shital Gandhi; Michael D Hill; Andra James; Thomas Jeerakathil; Albert Jin; Adam Kirton; Sylvain Lanthier; Andrea Lausman; Lisa Rae Leffert; Jennifer Mandzia; Bijoy Menon; Aleksandra Pikula; Alexandre Poppe; Gustavo Saposnik; Mukul Sharma; Sanjit Bhogal; Elisabeth Smitko; M Patrice Lindsay Journal: Int J Stroke Date: 2018-07-18 Impact factor: 5.266
Authors: Shital J Patel; Deborah L Reede; Douglas S Katz; Raja Subramaniam; Judith K Amorosa Journal: Radiographics Date: 2007 Nov-Dec Impact factor: 5.333
Authors: Richard H Swartz; Megan L Cayley; Norine Foley; Noor Niyar N Ladhani; Lisa Leffert; Cheryl Bushnell; J A McClure; M Patrice Lindsay Journal: Int J Stroke Date: 2017-10 Impact factor: 5.266
Authors: William J Powers; Alejandro A Rabinstein; Teri Ackerson; Opeolu M Adeoye; Nicholas C Bambakidis; Kyra Becker; José Biller; Michael Brown; Bart M Demaerschalk; Brian Hoh; Edward C Jauch; Chelsea S Kidwell; Thabele M Leslie-Mazwi; Bruce Ovbiagele; Phillip A Scott; Kevin N Sheth; Andrew M Southerland; Deborah V Summers; David L Tirschwell Journal: Stroke Date: 2019-10-30 Impact factor: 7.914
Authors: Jonathan Emberson; Kennedy R Lees; Patrick Lyden; Lisa Blackwell; Gregory Albers; Erich Bluhmki; Thomas Brott; Geoff Cohen; Stephen Davis; Geoffrey Donnan; James Grotta; George Howard; Markku Kaste; Masatoshi Koga; Ruediger von Kummer; Maarten Lansberg; Richard I Lindley; Gordon Murray; Jean Marc Olivot; Mark Parsons; Barbara Tilley; Danilo Toni; Kazunori Toyoda; Nils Wahlgren; Joanna Wardlaw; William Whiteley; Gregory J del Zoppo; Colin Baigent; Peter Sandercock; Werner Hacke Journal: Lancet Date: 2014-08-05 Impact factor: 79.321
Authors: Mustafa Ozbayrak; Iffet Cavdar; Mehmet Seven; Lebriz Uslu; Nami Yeyin; Handan Tanyildizi; Mohammad Abuqbeitah; A Serdar Acikgoz; Abdullah Tuten; Mustafa Demir Journal: Korean J Radiol Date: 2015-10-26 Impact factor: 3.500